TERAPIE VENETOCLAX + AZACYTIDIN U PACIENTŮ S AKUTNÍ MYELOIDNÍ LEUKEMIÍ (AML) VEDE JEN ZŘÍDKA K ELIMINACI LEUKEMICKÉHO KLONU, I KDYŽ JE PŘÍTOMNA MORFOLOGICKÁ REMISE
Title in English | VENETOCLAX + AZACYTIDINE THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) RARELY RESULTS IN THE ELIMINATION OF THE LEUKAEMIC CLONE, EVEN WHEN MORPHOLOGICAL REMISSION IS PRESENT |
---|---|
Authors | |
Year of publication | 2024 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | VENETOCLAX + AZACYTIDINE THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) RARELY RESULTS IN THE ELIMINATION OF THE LEUKAEMIC CLONE, EVEN WHEN MORPHOLOGICAL REMISSION IS PRESENT - conference abstract. |
Related projects: |